Why causal AI is becoming pharma’s next strategic differentiator — from target validation to clinical trials and real-world evidence. Visualizing the Ladder of Causation in Pharma: from seeing correlations, to doing interventions, to imagining counterfactuals — the foundation of causal AI in drug discovery. Introduction: The Limits of Correlation in Drug Discovery Drug discovery today generates unprecedented volumes of data. Omics, imaging, electronic health records, and real

Partnership with Professor Tsong-Long Hwang of CGUST to explore AI-powered innovations in small molecule drug design Vizuro Apotek AI Drug Discovery Platform x Industry-Academia Collaboration with CGUST Taipei | [August 22, 2025] — Vizuro LLC, a leading innovator in multimodal causal AI  and generative AI  technology, announced today that it has signed a Memorandum of Understanding (MOU) with Tsong-Long Hwang, Ph.D., Vice President and Distinguished Professor at Chang Gung U

Empowering Clinicians and General Populations with Actionable Insights Diabetes is one of the world’s fastest-growing health crises,...